×

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

  • US 8,008,323 B2
  • Filed: 04/13/2010
  • Issued: 08/30/2011
  • Est. Priority Date: 01/16/2003
  • Status: Expired due to Term
First Claim
Patent Images

1. A method of treating schizophrenia in a patient, comprising administering to a patient having schizophrenia a therapeutically effective amount of a compound of formula (I):

View all claims
  • 3 Assignments
Timeline View
Assignment View
    ×
    ×